UNSPSC 51413403: Dihydroergocristine

This classification denotes a dopamine agonist and alpha-adrenergic blocking agent with the molecular formula C35H41N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 05D48LUM4Z, chemically known as ergocristine, dihydro- but generally known as dihydroergocristine, which bears US NIH Compound Identifier 3065. European Medicines Agency schedules Dihydroergocristine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13586MIG.

UNSPSC 51413403 Dihydroergocristine, a Commodity code, represents emergency medical pharmaceuticals that state and local governments procure for fire rescue, emergency medical services, and related public-safety operations. The recent Tampa Fire Rescue solicitation shows that public health agencies are buying specific pharmaceutical line items for Advanced Life Support protocols — in this case Labetalol, Epinephrine, Adenosine, and Diltiazem vials and injections — under codes nominally anchored to individual drug names. State and local issuing bodies soliciting under this code include city purchasing departments on behalf of fire rescue services and emergency medical operations. Vendors must meet strict pharmaceutical compliance requirements: expiration dates of nine months or more from acceptance, firm pricing inclusive of freight to the delivery point, OSHA Safety Data Sheet compliance, and WCAG 2.2 Level AA accessibility documentation. Contracts typically run for one year with renewal options and may include set-asides for Small Local Business Enterprises (SLBEs).

The City of Tampa's Purchasing Department issued IFB 26P00188 on April 24, 2026, with an April 8, 2026 response deadline and an estimated contract value of $40,000.00 for a one-year term with two one-year renewal options. The Tampa Fire Rescue procurement required 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with ten-calendar-day delivery timelines and a 365-day warranty against defects. The City designated the contract for SLBE sheltered market participation with a 5 percent bid discount (capped at $10,000), though no SLBE subcontracting goals were established. Beyond this Florida opportunity, the recent-opportunities block contains limited geographic or issuing-body data to characterize broader activity under this code.